Insiders are Amassing These 10 Stocks in April
Can I make money investing in stocks that insiders are buying? Is there any link between stock returns and insider buying and selling activity.
Audentes Therapeutics Inc. (BOLD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Eversept Partners Kamran Moghtaderi | 0 | $0 | 0% | |
| 2. | Davidson Kempner Thomas Lenox Kempner | 0 | $0 | 0% | |
| 3. | Syquant Capital Olivier Leymarie And Henri Jeantet | 0 | $0 | 0% | |
| 4. | Foresite Capital Jim Tananbaum | 0 | $0 | 0% | |
| 5. | Maso Capital Manoj Jain And Sohit Khurana | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.50 | 168,082 | Other | 2,500,113 | 2017-04-24 | Filing | |
| $14.50 | 4,331 | Other | 64,431 | 2017-04-24 | Filing | |
| $15.00 | 219 | Director | 11,308 | 2016-07-25 | Filing | |
| $15.00 | 34,781 | Director | 1,795,524 | 2016-07-25 | Filing | |
| $15.00 | 219 | Large Shareholder | 11,308 | 2016-07-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.60 | 1,000 | Director | 13,678 | 2019-12-23 | Filing | |
| $59.60 | 10,000 | Director | 265,799 | 2019-12-23 | Filing | |
| $30.00 | 14,426 | Officer, Director | 113,394 | 2019-11-08 | Filing | |
| $32.18 | 1,000 | Director | 14,678 | 2019-09-23 | Filing | |
| $32.66 | 245 | Director | 275,799 | 2019-09-23 | Filing |
Institutional Investors' Holdings
News See All
2019 Review: Most Favored Hedge Fund Stocks vs. Audentes Therapeutics, Inc. (BOLD)
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade...
Hedge Funds Are Souring On Audentes Therapeutics, Inc. (BOLD)
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
Hedge Funds Have Never Been This Bullish On Audentes Therapeutics, Inc. (BOLD)
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Have Never Been This Bullish On Audentes Therapeutics, Inc. (BOLD)
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small...
Hedge Funds Have Never Been This Bullish On Audentes Therapeutics, Inc. (BOLD)
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with...
Is Audentes Therapeutics, Inc. (BOLD) Going to Burn These Hedge Funds?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
13G Filing: Adage Capital Management and Audentes Therapeutics Inc (BOLD)
Adage Capital Partners GP, L.L.C., a limited liability company organized under the laws of the State of Delaware ("ACPGP"), as general partner of ACP with respect to the shares of Common Stock directly...
13G Filing: James E. Flynn and Audentes Therapeutics Inc (BOLD)
You can access the original SEC filing by clicking here.
How Hedge Funds Played the Audentes Therapeutics Inc (BOLD) IPO
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don...